The WATCH D3 builds on a decade of development, shifting from basic heart rate tracking to the complex task of wrist-based blood pressure management. Following the 2021 debut of the original Watch D and the 2024 launch of the D2, this new model emphasizes both physical refinement and expanded diagnostic utility. Huawei has reduced the device’s thickness and strap weight, aiming to improve comfort for the 24-hour monitoring cycles that defined its predecessor.
Huawei Previews WATCH D3 Blood Pressure Monitor at ESC Congress 2026
In the halls of Munich’s ESC Congress 2026, Huawei has offered a first look at the WATCH D3, the latest iteration of its wrist-worn ambulatory blood pressure monitoring technology. The device, which precedes a formal launch on September 2, arrives as the company pushes further into clinical-grade consumer health hardware.
Technological refinements allow the device to capture blood pressure data across a wider range of activities, including measurements taken before and after exercise. The unit has secured CE MDR certification in the European Union, covering stationary, ambulatory, and exercise-based monitoring. Beyond core cardiovascular tracking, the D3 introduces environmental awareness, featuring reminders for high-altitude conditions and rapid temperature shifts. While the device integrates broader wellness metrics—such as sleep and emotional tracking—the company notes that these features serve as supplemental health insights rather than diagnostic tools.
Comments (0)
No comments yet. Be the first!